Bleakley Financial Group »

Takeda Pharmaceutical shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.5M 242k 14.27
2023-09-30 $3.3M 214k 15.47
2023-06-30 $3.3M 213k 15.71
2023-03-31 $3.2M 195k 16.48
2022-12-31 $3.2M 202k 15.60

More positions owned by Bleakley Financial Group

Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Sprott Physical Gold & Silve Tr Unit (CEF)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)
Ishares Silver Tr Ishares (SLV)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Bleakley Financial Group

Top funds holding Takeda Pharmaceutical

Millennium Management
Goldman Sachs Group
Brandes Investment Partners
Arrowstreet Capital, Limited Partnership
Polygon Management
Managed Asset Portfolios
Van Eck Associates Corp.
Causeway Capital Management
Y.D. More Investments
Jane Street
Citadel Advisors
Bank of America Corporation
Wells Fargo & Company
Natixis Asset Management Advisors
Nomura Holdings

View all funds holding Takeda Pharmaceutical